Stockreport

ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential [Yahoo! Finance]

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF ANI Pharmaceuticals agreed to acquire Alimera Sciences, adding eye disease treatments Iluvien and Yutiq to its rare disease portfolio. The deal expands ANI Pharmaceut [Read more]